dock_to_right
arrow_back
Terminology chevron_right Descriptions chevron_right 3977426013 - Administration of second dose of vaccine product containing only five component acellular Bordetella pertussis, Clostridium tetani, Corynebacterium diphtheriae, Haemophilus influenzae type B and inactivated whole Human poliovirus antigens (procedure) (en)
Production